Filter by
Documents (93)
RSSShowing results 60 to 80
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-11/doc_icon_1.jpg?itok=-CTC-HTw)
ACT EU priority areas for possible EU-level funding
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-11/doc_icon_0.jpg?itok=Q2n3Ru-0)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 October 2023)
![Document icon](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-11/doc_icon.jpg?itok=plqKo4qm)
Highlighted
ACT EU multi-annual workplan 2023-2026
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-10/doc_icon.jpg?itok=rpKR5NQ0)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-30 September 2023)
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_18.jpg?itok=QJIUtizO)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 August 2023)
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_10.jpg?itok=ur7G5HK_)
Kick-off meeting report - ACT EU multi-stakeholder platform
The summary report of the first ACT EU MSP workshop held in June 2023, to understand different stakeholder perspectives on how to transform the EU environment for clinical trials, discuss the feedback from the MSP public consultation and agree on a model for the establishment of the MSP.
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_16.jpg?itok=wqYag2J4)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-30 June 2023, edition 15)
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_15.jpg?itok=9-O2WUc_)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 May 2023, edition 14)
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_14.jpg?itok=__bH14Qw)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-30 April 2023, edition 13)
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_13.jpg?itok=hySXgzkl)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 March 2023, edition 12)
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_12.jpg?itok=Tc43_-8B)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-28 February 2023, edition 11)
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_11.jpg?itok=BJaUiAJm)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 January 2023, edition 10)
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_9.jpg?itok=vuFBj9CJ)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 December 2022, edition 9)
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_8.jpg?itok=IkpwCMV7)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-30 November 2022, edition 8)
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_7.jpg?itok=w_V268Yj)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 October 2022, edition 7)
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_6.jpg?itok=1E-O0DeZ)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-30 September 2022, edition 6)
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_5.jpg?itok=rvbnQAH5)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 August 2022, edition 5)
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_4.jpg?itok=RaFtNY-1)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 July 2022, edition 4)
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_3.jpg?itok=M-QqroWA)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-30 June 2022, edition 3)
![Document icon.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_small_no_crop/public/2023-09/doc_icon_2.jpg?itok=tSYCrlIc)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 May 2022, edition 2)